STUDY OF THE RED BLOOD CELL INDICES AND COAGULATION PROFILE IN RELATION WITH GLYCATED HEMOGLOBIN (HbA1c) IN TYPE 2 DIABETES MELLITUS INDIVIDUALS AT A TERTIARY CARE HOSPITAL.
Main Article Content
Keywords
Type 2 Diabetes mellitus, Red blood cell indices, MCH, HbA1c, coagulation profile, Glycemic control, thrombotic complications.
Abstract
INTRODUCTION: Diabetes mellitus (DM) is characterized by hyperglycemia(1). The effect of hyperglycemia in altering the aggregation and deformability of RBCs and the reduction in the lifespan of RBCs, is hypothesized to bring changes in these RBC indices. The aim of this study is to assess the red blood cell indices and coagulation impairment in type 2 diabetes mellitus (T2DM) patient, thereby preventing thromboembolic complications.
MATERIAL AND METHODS: This is a hospital-based, cross-sectional study which was conducted at SSIMS and RC hospital, Davanagere from January 2024 to May 2024. 110 cases of T2DM aged above 30 years with HbA1C ≥ 7 were included in this study. RBC count, Hb, HCT, MCV, MCH, MCHC, RDW, HbA1c, PT, INR, aPTT were measured.
RESULT: In this study, males comprised 68.1% of the participants. 45% of participants were in the age group of 51-60 years. Patients with poor glycemic control exhibited low MCH values. The study showed that, the patient with HbA1c >9 showed reduced prothrombin time.
CONCLUSION: This study shows that T2DM patients with HbA1C ≥ 9 have procoagulant state suggesting increased risk of stroke or Myocardial infarction and lower MCH levels in the context of poor glycemic control can serve as an indicator of the risk of developing DM-related vascular complications.
References
2. Jayaraj AT. A study on the relationship between RBC indices and glycemic control and its association with microvascular complications in type 2 diabetes mellitus. International Journal of Academic Medicine and Pharmacy. 2023 Oct 18;5(5):1142–6.
3. Kumar DTA, Department of General Medicine. A cross sectional study of coagulation profile in Type 2 diabetes mellitus patients in correlation with HbA1c. J Med Sci Clin Res. 2023;11(09):53–9.
4. Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2_suppl):25–32.
5. Arkew M, Asmerom H, Tesfa T, Tsegaye S, Gemechu K, Bete T, et al. Red blood cell parameters and their correlation with glycemic control among type 2 diabetic adult patients in eastern Ethiopia: A comparative cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:3499–507.
6. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32(1):187–92.
7. Kumar A, Gangwar R, Zargar AA, Kumar R, Sharma A. Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition. Current Diabetes Reviews. 2023 Apr 18;20(1).
8. Allahyani M. Association of the red cell distribution width with the glycemic index and lipid profile in patients with type 2 diabetes mellitus. Cureus. 2023.
9. Ahmad S, Rashid HM, Rahman WU, Mujahid M, Waleed HM, Shahzad W. Assessment of Variations in PT. APTT and Platelet Count and Their Correlation with Glycated Hemoglobin in Type 2 Diabeties mellitus. 2021;12:108–12.
10. Bhutto AR, Abbasi A, Abro AH. Correlation of hemoglobin A1c with red cell width distribution and other parameters of red blood cells in type II diabetes mellitus. Cureus. 2019;11:8.
11. Andleeb F, Atiq A, Atiq M, Atiq M. Hemoglobin structure at higher levels of hemoglobin A1C in type 2 diabetes and associated complications. Chinese Med J. 2020;133(10):1138–1143.